Literature DB >> 8981310

Excess glutamate in the cerebrospinal fluid in bacterial meningitis.

M Spranger1, S Krempien, S Schwab, M Maiwald, K Bruno, W Hacke.   

Abstract

We investigated possible neurotoxic components in the cerebrospinal fluid (CSF) of patients with bacterial meningitis. On murine cerebellar neuronal cell cultures, CSF exerted a dose-dependent toxic effect, which was attenuated by the NMDA receptor antagonist MK-801. Glutamate concentrations in the CSF of patients with bacterial meningitis were measured by an enzymatic assay and found to be significantly elevated (p < 0.001) as compared to viral meningitis and non-inflammatory neurological diseases. The concentration of glutamate in the CSF of patients with bacterial meningitis varied considerably and correlated with the severity of the disease as scored by the Glasgow Coma Scale. Cells in the CSF, mainly comprising polymorphonuclear granulocytes, did not release any glutamate into the culture medium, whereas blood monocytes produced remarkable amounts. These findings implicate an important role of monocytic inflammatory cells in bacterial meningitis by the release of glutamate, which may contribute to neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981310     DOI: 10.1016/s0022-510x(96)00197-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Authors:  Ming Jia; Steve A Noutong Njapo; Vaibhav Rastogi; Vishnumurthy Shushrutha Hedna
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

2.  The activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotection.

Authors:  Alexander Zlotnik; Yael Klin; Benjamin F Gruenbaum; Shaun E Gruenbaum; Sharon Ohayon; Mathew Boyko; Eyal Sheiner; Barak Aricha-Tamir; Yoram Shapira; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

3.  Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.

Authors:  Evgeni Brotfain; Ruslan Kutz; Julia Grinshpun; Benjamin F Gruenbaum; Shaun E Gruenbaum; Amit Frenkel; Agzam Zhumadilov; Vladimir Zeldetz; Yoav Bichovsky; Matthew Boyko; Moti Klein; Alexander Zlotnik
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

4.  The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.

Authors:  Matthew Boyko; Israel Melamed; Benjamin Fredrick Gruenbaum; Shaun Evan Gruenbaum; Sharon Ohayon; Akiva Leibowitz; Evgeny Brotfain; Yoram Shapira; Alexander Zlotnik
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

5.  Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis.

Authors:  Cornelia Blaser; Matthias Wittwer; Denis Grandgirard; Stephen L Leib
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

6.  Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.

Authors:  Matthew Boyko; David Stepensky; Benjamin F Gruenbaum; Shaun E Gruenbaum; Israel Melamed; Sharon Ohayon; Michael Glazer; Yoram Shapira; Alexander Zlotnik
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

7.  Sleep disorders are long-term sequelae of both bacterial and viral meningitis.

Authors:  H Schmidt; S Cohrs; T Heinemann; C Goerdt; M Djukic; B Heimann; C-W Wallesch; R Nau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 8.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

9.  The meningococcal ABC-Type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice.

Authors:  Roberta Colicchio; Susanna Ricci; Florentia Lamberti; Caterina Pagliarulo; Chiara Pagliuca; Velia Braione; Tiziana Braccini; Adelfia Talà; Donatella Montanaro; Sergio Tripodi; Marcella Cintorino; Giancarlo Troncone; Cecilia Bucci; Gianni Pozzi; Carmelo B Bruni; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

10.  Bacterial cytolysin during meningitis disrupts the regulation of glutamate in the brain, leading to synaptic damage.

Authors:  Carolin Wippel; Jana Maurer; Christina Förtsch; Sabrina Hupp; Alexandra Bohl; Jiangtao Ma; Timothy J Mitchell; Stephanie Bunkowski; Wolfgang Brück; Roland Nau; Asparouh I Iliev
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.